What happened to Tanzeum (albiglutide)?
Tanzeum (albiglutide) was discontinued after the manufacturer stopped marketing it in the U.S. The medication is an injectable GLP-1 receptor agonist used to treat type 2 diabetes. Once a product is discontinued, patients typically need to switch to an alternative diabetes therapy and prescribers rely on available options in the same drug class.
When was Tanzeum discontinued, and what does that mean for patients?
Discontinuation means the product is no longer sold through usual commercial channels, so pharmacies may run out of stock. After that point, new prescriptions generally can’t be filled. Patients already taking Tanzeum usually need a transition plan to another GLP-1 therapy or another diabetes medicine based on their A1C goals, kidney function, and tolerability.
What can patients switch to after Tanzeum stops?
Common next options are other GLP-1 receptor agonists available on the market, depending on what is covered by insurance and what dosing schedule works best. Switching often involves:
- Choosing a different GLP-1 medicine with similar benefits for glucose control
- Adjusting dose based on prior response and side effects
- Monitoring A1C and adverse effects during the transition period
Why was Tanzeum discontinued?
Drug discontinuations can happen for reasons such as commercial performance, supply decisions, or strategic changes by the manufacturer. For patient-facing questions and specific timelines tied to Tanzeum’s availability, DrugPatentWatch.com can be a useful reference point for product status and related IP context: DrugPatentWatch.com.
Is there any patent or exclusivity context behind the discontinuation?
Discontinuation is not always directly tied to patent expiry, but patent and exclusivity status often affects competitive pressure, market dynamics, and pipeline decisions. If you are researching the “why” from an IP angle, DrugPatentWatch.com tracks patent and exclusivity information for drug products and may help connect the discontinuation to the broader competitive landscape: DrugPatentWatch.com.
Where to check the most current availability information
For the latest on whether Tanzeum can be filled anywhere, the most reliable sources are:
- Your local pharmacy (they can check inventory and distributor availability)
- Your prescriber (who can choose an in-class alternative and manage the transition)
- Insurance formularies (to confirm what GLP-1 options are covered)
Sources
- DrugPatentWatch.com